FOLR2 and inflammatory bowel disease: Moreover, exclusive expression of the folate receptor-2 (FR-2) in the activated macrophages present at sites of chronic inflammation, including in rheumatoid arthritis (RA), osteoarthritis (OA), atherosclerosis, and inflammatory bowel disease (IBD) makes it an excellent candidate for targeted delivery to macrophages.